Home
Resources
Publications
Steady-state Bioavailability of Dexbrompheniramine and Pseudoephedrine From a Repeat-Action Combination Tablet

Steady-state Bioavailability of Dexbrompheniramine and Pseudoephedrine From a Repeat-Action Combination Tablet

C C Lin, H K Kim, J Lim, C Digiore, S Symchowicz, R Gural

J Pharm Sci. 1985 Jan;74(1):25-8.

PMID: 3981411

Abstract:

The steady-state bioavailabilities of dexbrompheniramine and pseudoephedrine were evaluated following multiple-dose administrations of a repeat-action combination tablet containing 6 mg of dexbrompheniramine maleate with 120 mg of pseudoephedrine sulfate every 12 h for 7 d compared with reference standards. The reference standards used in this study were concomitant administration of conventional 2-mg dexbrompheniramine maleate tablets every 4 h and 120-mg pseudoephedrine sulfate repeat-action tablets every 12 h, each for 7 d. Twelve healthy adult male volunteers completed this randomized two-way crossover study. Blood samples for subsequent assay were obtained at frequent time intervals throughout each 7-d dosing phase. Sensitive and specific gas-liquid chromatographic methods were used for the determination of dexbrompheniramine and pseudoephedrine in plasma. Based on the plasma levels, the times to reach steady state were determined. In addition, the major bioavailability parameters (Cmin, Cmax, tmax, and AUC) for days 6 and 7 of dosing were determined and statistically evaluated. The results of this study demonstrate that, at steady state, the repeat-action combination tablet and concomitant administration of the reference standards are bioequivalent.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP2391039	Dexbrompheniramine maleate		2391-03-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: